Basic Information
RNALocate ID: | RLID:11003014 |
RNA Symbol: | hsa-miR-497-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-497-5p |
RNA ID: | miRBase:MIMAT0002820 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002346 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002347 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002348 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11003013 | Exosome | Brain tissue | 23382797 |
RLID:11003015 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11003016 | Microvesicle | Seminal plasma | 23539611 |
RLID:11003017 | Microvesicle | Follicular fluid | 23666971 |
RLID:11003018 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000155 | Exosome | Mast cells | |
RLID-D:11000487 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-497-5p | Diffuse large b cell lymphoma | MNDR-E-MI-54882 |
MNDR | hsa-miR-497-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-54883 |
MNDR | hsa-miR-497-5p | Oral squamous cell carcinoma | MNDR-E-MI-54884 |
MNDR | hsa-miR-497-5p | Large cell neuroendocrine cancer | MNDR-E-MI-54885 |
MNDR | hsa-miR-497-5p | Medulloblastoma | MNDR-E-MI-54886 |
MNDR | hsa-miR-497-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-54887 |
MNDR | hsa-miR-497-5p | Lymphoma | MNDR-E-MI-54888 |
MNDR | hsa-miR-497-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-54889 |
MNDR | hsa-miR-497-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-54890 |
MNDR | hsa-miR-497-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-54891 |
MNDR | hsa-miR-497-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-54892 |
MNDR | hsa-miR-497-5p | Her2-receptor positive breast cancer | MNDR-E-MI-54893 |
MNDR | hsa-miR-497-5p | Breast cancer luminal | MNDR-E-MI-54894 |
MNDR | hsa-miR-497-5p | Prostate cancer | MNDR-E-MI-54895 |
MNDR | hsa-miR-497-5p | Gastric cancer | MNDR-E-MI-54896 |
MNDR | hsa-miR-497-5p | Alzheimer disease | MNDR-E-MI-54897 |
MNDR | hsa-miR-497-5p | Intracranial aneurysm | MNDR-E-MI-54898 |
MNDR | hsa-miR-497-5p | Bladder cancer | MNDR-E-MI-54899 |
MNDR | hsa-miR-497-5p | Esophageal carcinoma | MNDR-E-MI-54900 |
MNDR | hsa-miR-497-5p | Sarcoma | MNDR-E-MI-54901 |
MNDR | hsa-miR-497-5p | Seizures | MNDR-E-MI-54902 |
MNDR | hsa-miR-497-5p | Head and neck cancer | MNDR-E-MI-54903 |
MNDR | hsa-miR-497-5p | Cardiovascular disease | MNDR-E-MI-54904 |
MNDR | hsa-miR-497-5p | Lung cancer | MNDR-E-MI-54905 |
MNDR | hsa-miR-497-5p | Parkinson disease | MNDR-E-MI-54906 |
MNDR | hsa-miR-497-5p | Basal-like breast cancer | MNDR-E-MI-54907 |
MNDR | hsa-miR-497-5p | Neuroendocrine neoplasia | MNDR-E-MI-54908 |
MNDR | hsa-miR-497-5p | Thyroid cancer | MNDR-E-MI-54909 |
MNDR | hsa-miR-497-5p | Pituitary neoplasms | MNDR-E-MI-54910 |
MNDR | hsa-miR-497-5p | Pancreatic cancer | MNDR-E-MI-54911 |
MNDR | hsa-miR-497-5p | Malignant melanoma | MNDR-E-MI-54912 |
MNDR | hsa-miR-497-5p | Rectum adenocarcinoma | MNDR-E-MI-54913 |
MNDR | hsa-miR-497-5p | Nephroblastoma | MNDR-E-MI-54914 |
MNDR | hsa-miR-497-5p | Colon cancer | MNDR-E-MI-54915 |
MNDR | hsa-miR-497-5p | Colon adenocarcinoma | MNDR-E-MI-54916 |
MNDR | hsa-miR-497-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-54917 |
MNDR | hsa-miR-497-5p | Familial ovarian cancer | MNDR-E-MI-54918 |
MNDR | hsa-miR-497-5p | Carcinoma ductal breast | MNDR-E-MI-54919 |
MNDR | hsa-miR-497-5p | Invasive ductal carcinoma | MNDR-E-MI-54920 |
MNDR | hsa-miR-497-5p | Glioblastoma | MNDR-E-MI-54921 |
MNDR | hsa-miR-497-5p | Astrocytoma | MNDR-E-MI-54922 |
MNDR | hsa-miR-497-5p | Glioma | MNDR-E-MI-54923 |
MNDR | hsa-miR-497-5p | Chordoma | MNDR-E-MI-54924 |
MNDR | hsa-miR-497-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-54925 |
MNDR | hsa-miR-497-5p | Temporal lobe epilepsy | MNDR-E-MI-54926 |
MNDR | hsa-miR-497-5p | Osteosarcoma | MNDR-E-MI-54927 |
MNDR | hsa-miR-497-5p | Breast carcinoma | MNDR-E-MI-54928 |
MNDR | hsa-miR-497-5p | Meningioma | MNDR-E-MI-54929 |
MNDR | hsa-miR-497-5p | Gastric adenocarcinoma | MNDR-E-MI-54930 |
MNDR | hsa-miR-497-5p | Cervical squamous cell carcinoma | MNDR-E-MI-54931 |
MNDR | hsa-miR-497-5p | Pituitary adenoma | MNDR-E-MI-54932 |
MNDR | hsa-miR-497-5p | Lung squamous cell carcinoma | MNDR-E-MI-54933 |
MNDR | hsa-miR-497-5p | Lung adenocarcinoma | MNDR-E-MI-54934 |
MNDR | hsa-miR-497-5p | Adrenocortical cancer | MNDR-E-MI-54935 |
MNDR | hsa-miR-497-5p | Thyroid carcinoma | MNDR-E-MI-54936 |
MNDR | hsa-miR-497-5p | Bladder urothelial carcinoma | MNDR-E-MI-54937 |
MNDR | hsa-miR-497-5p | Pancreatic adenocarcinoma | MNDR-E-MI-54938 |
MNDR | hsa-miR-497-5p | Cervical cancer | MNDR-E-MI-54939 |
MNDR | hsa-miR-497-5p | Carcinoma renal cell | MNDR-E-MI-54940 |
MNDR | hsa-miR-497-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-54941 |
MNDR | hsa-miR-497-5p | Clear cell renal cell carcinoma | MNDR-E-MI-54942 |
MNDR | hsa-miR-497-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-54943 |
MNDR | hsa-miR-497-5p | Large cell carcinoma | MNDR-E-MI-54944 |
MNDR | hsa-miR-497-5p | Cholangiocarcinoma | MNDR-E-MI-54945 |
MNDR | hsa-miR-497-5p | Esophageal cancer | MNDR-E-MI-54946 |
MNDR | hsa-miR-497-5p | Lung small cell carcinoma | MNDR-E-MI-54947 |
MNDR | hsa-miR-497-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-54948 |
MNDR | hsa-miR-497-5p | Testicular germ cell cancer | MNDR-E-MI-54949 |
MNDR | hsa-miR-497-5p | Breast invasive carcinoma | MNDR-E-MI-54950 |
MNDR | hsa-miR-497-5p | Hepatocellular carcinoma | MNDR-E-MI-54951 |
MNDR | hsa-miR-497-5p | Embryonal cancer | MNDR-E-MI-54952 |
MNDR | hsa-miR-497-5p | Familiar ovarian carcinoma | MNDR-E-MI-54953 |
MNDR | hsa-miR-497-5p | Rheumatoid arthritis | MNDR-E-MI-54954 |
MNDR | hsa-miR-497-5p | Barrett's adenocarcinoma | MNDR-E-MI-54955 |
MNDR | hsa-miR-497-5p | Hodgkin lymphoma | MNDR-E-MI-54956 |
MNDR | hsa-miR-497-5p | Burkitt lymphoma | MNDR-E-MI-54957 |
MNDR | hsa-miR-497-5p | Colorectal cancer | MNDR-E-MI-54958 |
MNDR | hsa-miR-497-5p | Uterine cervical neoplasms | MNDR-E-MI-54959 |
MNDR | hsa-miR-497-5p | Nasopharyngeal cancer | MNDR-E-MI-54960 |
MNDR | hsa-miR-497-5p | Aids dementia complex | MNDR-E-MI-54961 |
MNDR | hsa-miR-497-5p | Pancreatitis chronic | MNDR-E-MI-54962 |
MNDR | hsa-miR-497-5p | Barrett's carcinogenesis | MNDR-E-MI-54963 |
MNDR | hsa-miR-497-5p | Breast cancer her3+ negative | MNDR-E-MI-54964 |
MNDR | hsa-miR-497-5p | Duke A | MNDR-E-MI-54965 |
MNDR | hsa-miR-497-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-54966 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AGO4 | Homo sapiens | RR00056018 |
TOP